Author

Paula Jordan

Heidelberg University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

Andrew FreistaedteriD· 2 shared Huanting ChiiD· 2 shared Viet Loan Dao ThiiD· 2 shared Andreas PichlmairiD· 1 shared Antonio PirasiD· 1 shared Charlotta FunayaiD· 1 shared Charlotte Caroline Syren· 1 shared Di Ge· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

Andrew FreistaedterORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ZDHHC17-Mediated Palmitoylation of Hepatitis E Virus ORF3 Protein Regulates Vectorial Trafficking in Polarized Epithelial Cells

Patrick Broescky, Charlotte Caroline Syren, Di Ge, Leonid Kostrykin, Antonio Piras, Zoé Engels, Andrew Freistaedter, Huanting Chi, Paula Jordan, Charlotta Funaya, K Rohr, Sandhya P. Tiwari, Thibault Tubiana, Andreas Pichlmair, Viet Loan Dao Thi

This study identifies ZDHHC17-mediated palmitoylation of HEV ORF3 protein as critical for directional secretion in polarized epithelial cells.

bioRxiv · Jun 18, 2026 · PreprintCell Biology

The nucleotide analog bemnifosbuvir inhibits hepatitis E virus replication in preclinical models

Jungen Hu, Tianxu Liu, Mara Klöhn, Andrew Freistaedter, Elif Toprak, Huanting Chi, Paula Jordan, Xinyue Yang, Johanna Becker, Volker Lohmann, Eike Steinmann, Lin Wang, Viet Loan Dao Thi

This study identifies bemnifosbuvir as a potent inhibitor of hepatitis E virus replication in vitro and in a gerbil model, with additive effects when combined with ribavirin.

bioRxiv · Aug 15, 2025 · PreprintMicrobiology